Company Filing History:
2 out of 880 
1 out of 6 Years Active: 2007-2009
Title: Innovations of Junichi Hata in Recombinant Protein Production
Introduction
Junichi Hata is a notable inventor based in Mishima-gun, Japan. He has made significant contributions to the field of biotechnology, particularly in the production of recombinant proteins. With a total of two patents to his name, Hata's work focuses on enhancing protein expression systems.
Latest Patents
Hata's latest patents include a process for the production of a recombinant protein and a fusion protein. This invention provides a recombinant protein expression system utilizing a host and cell-free translation system. It is capable of universally expressing a large amount of any protein as a soluble protein while preventing toxicity in hosts, the formation of inclusion bodies, and decomposition by proteases. The process involves expressing the desired protein as a fusion protein with chaperonins, such as approximately 60 kDa molecular chaperones, 60 kDa heat shock proteins, or thermosomes. The desired protein is accommodated inside the stereostructure of a chaperonin. The invention outlines a process for producing a protein that includes transcribing and translating a gene containing a gene encoding the linked chaperonin subunits and a gene encoding the desired protein, thereby synthesizing a fusion protein linked via a peptide linkage to the chaperonin subunits.
Career Highlights
Throughout his career, Junichi Hata has worked with prominent companies such as Sekisui Chemical Co., Ltd. and Marine Biotechnology Institute Co., Ltd. His experience in these organizations has contributed to his expertise in the field of biotechnology and protein production.
Collaborations
Hata has collaborated with notable individuals in his field, including Masahiro Furutani and Akiko Togi. These collaborations have likely enriched his research and development efforts.
Conclusion
Junichi Hata's innovations in recombinant protein production demonstrate his significant impact on biotechnology. His patents reflect a commitment to advancing the field and improving protein expression systems.